These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7155375)

  • 21. [The therapy of peripheral circulatory disorders (angiooganopathies) with a blood extract].
    Schirren C; Dietrich K; Biel F
    Hautarzt; 1967 Jun; 18(6):260-4. PubMed ID: 5593511
    [No Abstract]   [Full Text] [Related]  

  • 22. [Complamine in obliterating peripheral circulatory disorders].
    Kusztos D; Bereczky M; Fono J
    Med Monatsschr; 1970 Mar; 24(3):127-8. PubMed ID: 5436974
    [No Abstract]   [Full Text] [Related]  

  • 23. [Action of Sadamin, Polfa].
    Lukjan H; Bielawiec M; Bogdanikowa B; Kiersnowska B; Korfel B; Dowzyk W
    Pol Tyg Lek; 1972 May; 27(20):739-40. PubMed ID: 5029663
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment with nicotinic acid. II. Clinical experience].
    Carlson LA; Orö L
    Lakartidningen; 1966 Nov; 63(45):4281-7. PubMed ID: 5978872
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experiences with new Cosaldon forms].
    Dammann C
    Med Klin; 1969 Feb; 64(8):344-8. PubMed ID: 5783023
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinico-instrumental evaluation of ciclonicate in the therapy of obliterating arteriopathies of the lower extremities in Fontaine's stage II].
    Feliciotti F; De Carolis G; Mariotti C; Mingolla F
    Ann Ital Chir; 1983; 55(5):493-7. PubMed ID: 6673630
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical valuation of "Plasmaclar", a new drug for the treatment of hyperlipaemias (author's transl)].
    Ferrer García JL
    Folia Clin Int (Barc); 1973 Nov; 23(11):782-94. PubMed ID: 4773216
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the treatment of hyperlipemia with theophylline nicotinate].
    Ciammaichella A
    Atti Soc Ital Cardiol; 1969 Jan; 2():251-60. PubMed ID: 5406537
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the treatment of arteriosclerosis in private practice].
    Wittenstein E
    Ther Ggw; 1965 Nov; 104(11):1514-22. PubMed ID: 5885570
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment with nicotinic acid. IV. Laboratory control].
    Sundblad L; Ost CR
    Lakartidningen; 1966 Nov; 63(45):4293-7 passim. PubMed ID: 5981584
    [No Abstract]   [Full Text] [Related]  

  • 31. [Arteriosclerosis and nicotinic acid therapy. 4. Nicotinic acid therapy].
    Ribom U
    Lakartidningen; 1971 Apr; 68(15):1750-2. PubMed ID: 5577246
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical experience with -tocopherolnicotinate in arterious peripheral circulation disorders].
    Michael RJ
    Dtsch Med J; 1971 Oct; 22(20):654-6. PubMed ID: 5120336
    [No Abstract]   [Full Text] [Related]  

  • 33. Contributions of vasoactive substances in cases of chronic arteriosclerotic occlusion in the lower extremities.
    Numata M
    Methods Find Exp Clin Pharmacol; 1982; 4(3):199-202. PubMed ID: 7121130
    [No Abstract]   [Full Text] [Related]  

  • 34. [The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination].
    Hüdepohl M; Bockelmann R
    Med Klin; 1966 Feb; 61(5):184-6. PubMed ID: 5982907
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of peripheral circulatory disorders with a nicotinic acid derivative].
    Kienholz E
    Med Klin; 1965 Aug; 60(33):1321-4. PubMed ID: 5843335
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical assessment of Cardilan].
    Markiewicz M; Korolko A
    Pol Tyg Lek; 1970 Nov; 25(47):1816-7. PubMed ID: 5484526
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the therapy of central and peripheral blood circulation disorders].
    Weihrauch H
    Hippokrates; 1967 Sep; 38(18):739-42. PubMed ID: 5610064
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of fibrinolysis activation on the peripheral blood circulation in occlusive vascular diseases].
    Bielawiec M; Lukjan H
    Med Monatsschr; 1971 Jul; 25(7):312-4. PubMed ID: 5563915
    [No Abstract]   [Full Text] [Related]  

  • 39. [Electroencephalographic study in patients with cerebral arteriosclerotic lesions. Modifications induced by hemokinetic treatment in course of a barbiturate narcosis].
    Ruggerini R; Grugni P; Bolognesi L; Romitti M; Poggi G; Senini G
    Minerva Anestesiol; 1971 Apr; 37(4):164-73. PubMed ID: 5566169
    [No Abstract]   [Full Text] [Related]  

  • 40. [Proposals for a plan of fibrinolytic-clearing therapy of peripheral obstructive arteriopathy].
    Ferliga G
    G Gerontol; 1967 Aug; 15(8):955-71. PubMed ID: 4181505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.